The metastasis suppressor NME1 inhibits melanoma cell motility via direct transcriptional induction of the integrin beta-3 gene

M. Kathryn Leonard, Marián Novak, Devin Snyder, Grace Snow, Nidhi Pamidimukkala, Joseph R. McCorkle, Xiuwei H. Yang, David M. Kaetzel

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

Expression of the metastasis suppressor NME1 in melanoma is associated with reduced cellular motility, invasion, and metastasis, but mechanisms underlying these activities are not completely understood. Herein we report a novel mechanism through which NME1 drives formation of large, stable focal adhesions (FAs) in melanoma cells via induction of integrin β3 (ITGβ3), and in one cell line, concomitant suppression of integrin β1 (ITGβ1) transcripts. Forced expression of NME1 resulted in a strong activation of the promoter region (−301 to +13) of the ITGB3 gene. Chromatin immunoprecipitation (ChIP) analysis revealed the transcriptional induction was associated with direct recruitment of NME1 and an increase in the epigenetic activation mark, acetylation of histone 3 on lysine 27 (H3K27Ac) to a 1 kb stretch of 5’-flanking sequence of the ITGB3 gene. Unexpectedly, NME1 did not affect the amount either ITGβ1 or ITGβ3 proteins were internalized and recycled, processes commonly associated with regulating expression of integrins at the cell surface. The ability of NME1 to suppress motile and invasive phenotypes of melanoma cells was dependent on its induction of ITGβ3. Expression of ITGβ3 mRNA was associated with increased disease-free survival time in melanoma patients of the TCGA collection, consistent with its potential role as an effector of the metastasis suppressor function of NME1. Together, these data indicate metastasis suppressor activity of NME1 in melanoma is mediated by induction of ITGB3 gene transcription, with NME1-driven enrichment of ITGβ3 protein at the cell membrane resulting in attenuated cell motility through the stabilization of large focal adhesions.

Original languageEnglish
Pages (from-to)85-93
Number of pages9
JournalExperimental Cell Research
Volume374
Issue number1
DOIs
StatePublished - Jan 1 2019

Bibliographical note

Publisher Copyright:
© 2018 Elsevier Inc.

Funding

This work was supported by the National Institutes of Health/National Cancer Institute through research Grants (CA83237, CA159871 and CA159871-S1), a training grant (T32 CA154274), and an education grant (R25 GM055036) was funded by the National Institutes of Health/National Institute of General Medical Sciences. The study was also supported by a research grant from the Maryland Stem Cell Research Foundation ( MSCRFI-1638 ). The authors express their sincere appreciation to Dr. Alexey Belkin for his helpful advice throughout the project, and to Dr. Laurence Magder for his assistance with statistical analysis.

FundersFunder number
National Institutes of Health/National Cancer InstituteCA83237, R25 GM055036, CA159871-S1, CA159871, T32 CA154274
National Institutes of Health/National Institute of General Medical Sciences
National Childhood Cancer Registry – National Cancer InstituteT32CA154274
National Childhood Cancer Registry – National Cancer Institute
Maryland Stem Cell Research FundMSCRFI-1638
Maryland Stem Cell Research Fund

    Keywords

    • Cell motility
    • ITGβ3
    • Melanoma
    • Metastasis
    • NME1
    • Transcription

    ASJC Scopus subject areas

    • Cell Biology

    Fingerprint

    Dive into the research topics of 'The metastasis suppressor NME1 inhibits melanoma cell motility via direct transcriptional induction of the integrin beta-3 gene'. Together they form a unique fingerprint.

    Cite this